ATE229650T1 - Verfahren zur diagnose von diabetes und praediabetischer bedingungen - Google Patents

Verfahren zur diagnose von diabetes und praediabetischer bedingungen

Info

Publication number
ATE229650T1
ATE229650T1 AT94906796T AT94906796T ATE229650T1 AT E229650 T1 ATE229650 T1 AT E229650T1 AT 94906796 T AT94906796 T AT 94906796T AT 94906796 T AT94906796 T AT 94906796T AT E229650 T1 ATE229650 T1 AT E229650T1
Authority
AT
Austria
Prior art keywords
gad
pct
patient
preediabetic
conditions
Prior art date
Application number
AT94906796T
Other languages
English (en)
Inventor
Ian Reay Mackay
Merrill Joy Rowley
Paul Zev Zimmet
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash filed Critical Univ Monash
Application granted granted Critical
Publication of ATE229650T1 publication Critical patent/ATE229650T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT94906796T 1993-02-09 1994-02-09 Verfahren zur diagnose von diabetes und praediabetischer bedingungen ATE229650T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL716893 1993-02-09
PCT/AU1994/000056 WO1994018568A1 (en) 1993-02-09 1994-02-09 Methods for the diagnosis of diabetes and prediabetic conditions

Publications (1)

Publication Number Publication Date
ATE229650T1 true ATE229650T1 (de) 2002-12-15

Family

ID=3776693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94906796T ATE229650T1 (de) 1993-02-09 1994-02-09 Verfahren zur diagnose von diabetes und praediabetischer bedingungen

Country Status (12)

Country Link
US (1) US5770381A (de)
EP (1) EP0686262B1 (de)
JP (1) JP3510889B2 (de)
AT (1) ATE229650T1 (de)
CA (1) CA2155677A1 (de)
DE (1) DE69431874D1 (de)
IL (1) IL108587A (de)
NZ (1) NZ261541A (de)
SG (1) SG45161A1 (de)
TW (1) TW305936B (de)
WO (1) WO1994018568A1 (de)
ZA (1) ZA94845B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821334A (en) * 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
FR2759701B1 (fr) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
AU3958999A (en) * 1999-06-01 2000-12-18 Kyokuto Pharmaceutical Industrial Co., Ltd. Method for assaying anti-gad antibody and kit
EP2836845B1 (de) 2012-04-13 2018-05-09 DiabetOmics, Inc. Biomarker für schwangerschaftsdiabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
WO1992014485A1 (en) * 1991-02-22 1992-09-03 Amrad Corporation Limited A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
AU1749692A (en) * 1991-05-03 1992-12-21 Novo Nordisk A/S Islet cell autoantigen (gad) for the detection of preclinical diabetes

Also Published As

Publication number Publication date
WO1994018568A1 (en) 1994-08-18
JP3510889B2 (ja) 2004-03-29
IL108587A (en) 1998-01-04
CA2155677A1 (en) 1994-08-18
EP0686262B1 (de) 2002-12-11
EP0686262A1 (de) 1995-12-13
JPH08506417A (ja) 1996-07-09
US5770381A (en) 1998-06-23
NZ261541A (en) 1996-09-25
IL108587A0 (en) 1994-05-30
DE69431874D1 (de) 2003-01-23
TW305936B (de) 1997-05-21
SG45161A1 (en) 1998-01-16
ZA94845B (en) 1994-11-11
EP0686262A4 (de) 1997-06-04

Similar Documents

Publication Publication Date Title
Kannel et al. The prognostic significance of proteinuria: the Framingham study
CA1206877A (en) Immunoassay for nonenzymatically glucosylated proteins and protein fragments - an index of glycemia
Rosse et al. Paroxysmal nocturnal haemoglobinuria
DK0590071T3 (da) Hovedsagelig rene receptor-lignende TGF-BETA-1 bindende molekyler samt anvendelse deraf
Withold Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers
DE69016423D1 (de) Bestimmungsmethode für glykosyliertes hämoglobin.
ATE209356T1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
CA2104225A1 (en) Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
WYNN et al. Update on the epidemiology of multiple sclerosis
Dybkær Unit" katal" for catalytic activity (IUPAC Technical Report)
BR0009843A (pt) Método de diagnosticar encefalopatias esponjiformes transmissìveis
ATE68600T1 (de) Satz und verfahren zur diagnose der iganephropathie.
ATE229650T1 (de) Verfahren zur diagnose von diabetes und praediabetischer bedingungen
Shell et al. Early appearance of MB-creatine kinase activity in nontransmural myocardial infarction detected by a sensitive assay for the isoenzyme
Muhr et al. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
Ittyerah et al. Coagulation factor XIII concentration in sickle-cell disease
DE69431051D1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
RU2000119129A (ru) Молекула днк, кодирующая мутантный препронейропептид y, мутантный сигнальный пептид и их применения
US5518886A (en) Blood lead diagnostic assay
Stein et al. Creatine kinase variants
Symons et al. Effectiveness of analysis of free thyroxin concentration in serum for diagnosis of covert thyroid disease.
SU1274682A1 (ru) Способ диагностики сальмонеллеза у детей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties